DIGOXIN injection how supplied storage and handling

Digoxin
DIGOXIN injection^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
DIGOXIN tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information, click here.

16 HOW SUPPLIED/STORAGE AND HANDLING

Digoxin Injection USP, 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL)is available as follows:

NDC 0781-3059-95 ampules of 2 mL in boxes of 10

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light.